|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
16.550 +0.130 (+0.792%) Ranking Overview
Ranking based on 6 research report(s)
Average Ranking 2.17
|
Strong Buy (1)
0
|
Buy (2)
5
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 127.00 RMB (cts) | |
| Net Profit | 3,370.56 RMB (MIL) | DPS | 39.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 3,979.50 | 149.00 | 45.60 | -- | 4,675.00 | 3,664.00 |
| 2027 | 4,755.50 | 179.00 | 53.80 | -- | 4,777.00 | 4,091.00 |
| 2028 | 5,289.00 | 198.00 | 58.45 | -- | 5,721.00 | 4,638.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 4,020.00 | 151.90 | 45.60 | CITIGROUP | Buy | 35.30 | 26/03/2026 | |
| 2026 | 3,944.00 | 148.00 | -- | CITIC SEC | Buy | 32.00 | 08/04/2026 | |
| 2026 | 3,991.00 | 149.00 | 51.82 | MORGAN STANLEY | Overweight | 32.00 | 01/06/2026 | |
| 2026 | 4,675.00 | 175.00 | 53.00 | CSC | Buy | 26.50 | 06/02/2026 | |
| 2026 | 3,968.00 | 149.00 | 40.00 | CLSA | OutPerform | 25.40 | 29/04/2026 | |
| 2026 | 3,664.00 | 143.00 | 41.00 | HSBC | Hold | 18.30 | 10/07/2026 | |
| 2027 | 4,742.00 | 179.20 | 53.80 | CITIGROUP | -- | -- | 26/03/2026 | |
| 2027 | 4,769.00 | 179.00 | -- | CITIC SEC | -- | -- | 08/04/2026 | |
| 2027 | 4,777.00 | 179.00 | 62.19 | MORGAN STANLEY | -- | -- | 01/06/2026 | |
| 2027 | 4,772.00 | 179.00 | 54.00 | CSC | -- | -- | 06/02/2026 | |
| 2027 | 4,497.00 | 168.00 | 50.00 | CLSA | -- | -- | 29/04/2026 | |
| 2027 | 4,091.00 | 160.00 | 46.00 | HSBC | -- | -- | 10/07/2026 | |
| 2028 | 5,721.00 | 216.20 | 64.90 | CITIGROUP | -- | -- | 26/03/2026 | |
| 2028 | 5,289.00 | 198.00 | -- | CITIC SEC | -- | -- | 08/04/2026 | |
| 2028 | 5,454.00 | 204.00 | 71.07 | MORGAN STANLEY | -- | -- | 01/06/2026 | |
| 2028 | 4,881.00 | 183.00 | 50.00 | CLSA | -- | -- | 29/04/2026 | |
| 2028 | 4,638.00 | 181.00 | 52.00 | HSBC | -- | -- | 10/07/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 14/07/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 3,370,562 |
| %Change | 21.686% |
| EPS / (LPS) | RMB 1.270 |
| NBV Per Share (¥) | RMB 18.451 |